左旋肉碱在超未成熟儿脂类及胆红素代谢中的作用

doi:10.12372/jcp.2022.21e0730

Abstract

Abstract:

Objective To investigate the effect of L-carnitine on lipid and bilirubin metabolism in extremely premature infants (EPI). Methods The clinical data of preterm infants with gestational age <28 weeks hospitalized from August 2016 to December 2019 were retrospectively analyzed. Preterm infants were divided into L-carnitine group and non-L-carnitine group according to the prophylactic use of L-carnitine within 72 hours after admission, and the levels of lipids and bilirubin were compared between the two groups. Results A total of 261 EPI (151 boys and 110 girls) were enrolled, and the mean gestational age was (26.5±1.3) weeks and the mean birth weight was (907.3±175.9) g. There were 139 patients in L-carnitine group and 122 in non-L-carnitine group. The 1-minute Apgar score and the proportion of prenatal dexamethasone use in L-carnitine group were higher than those in non-L-carnitine group, and the differences were statistically significant (P<0.05). Compared with non-L-carnitine group, L-carnitine group had lower total bilirubin level at week 1 and 2, higher bile acid level at week 2, lower direct bilirubin level at week 4, higher triglyceride level at week 1, lower blood urea nitrogen and creatinine levels and higher alanine aminotransferase level at week 1 and 2, and the differences were statistically significant (P<0.05). Among 261 patients, 66 had parenteral nutrition associated cholestasis (PNAC), including 33 patients (23.7%) in the L-carnitine group and 33 (27.0%) in the non-L-carnitine group. Binary logistic regression analysis showed that triacylglycerol level at the fourth week of hospitalization was a risk factor for PNAC (P<0.05). There was no significant correlation between prophylactic use of L-carnitine and the occurrence of PNAC (P>0.05). Conclusions Early prophylactic use of L-carnitine in EPI can regulate bilirubin and lipid metabolism, but it will not reduce the incidence of PNAC, nor affect liver and kidney function.

Key words: L-carnitine, metabolism of lipid, metabolism of bilirubin, extremely premature infant

YU Yanliang, CHEN Xueyu, FAN Guoqing, CHEN Chun, LIN Bingchun, ZHAO Jie, HUANG Zhifeng, YANG Chuanzhong. Effect of L-carnitine on lipid and bilirubin metabolism in extremely premature infants[J].Journal of Clinical Pediatrics, 2022, 40(6): 431-435.

Figures/Tables 5

References 16

[1]	McNelis K, Fu TT, Poindexter B. Nutrition for the extremely preterm infant[J]. Clin Perinatol, 2017, 44(2): 395-406. doi: S0095-5108(17)30015-5 pmid: 28477668
[2]	Harding JE, Cormack BE, Alexander T, et al. Advances in nutrition of the newborn infant[J]. Lancet, 2017, 389(10079): 1660-1668. doi: S0140-6736(17)30552-4 pmid: 28443560
[3]	Lamhonwah AM, Barić I, Lamhonwah J, et al. Attention deficit/hyperactivity disorder as an associated feature in OCTN2 deficiency with novel deletion (p.T440-Y449)[J]. Clin Case Rep, 2018, 6(4): 585-591. doi: 10.1002/ccr3.1316
[4]	Ozturk MA, Kardas Z, Kardas F, et al. Effects of L~carnitine supplementation on respiratory distress syndrome development and prognosis in premature infants: a single blind randomized controlled trial[J]. Exp Ther Med, 2016, 11(3): 1123-1127. doi: 10.3892/etm.2015.2964
[5]	Liu Q, Wu J, Shen W, et al. Analysis of amino acids and acyl carnitine profiles in low birth weight, preterm, and small for gestational age neonates[J]. J Matern Fetal Neonatal Med, 2017, 30(22): 2697-2704. doi: 10.1080/14767058.2016.1261395
[6]	Sánchez-Pintos P, Pérez-Muñuzuri A, Cocho JÁ, et al. Evaluation of carnitine deficit in very low birth weight preterm newborns small for their gestational age[J]. J Matern Fetal Neonatal Med, 2016, 29(6): 933-937. doi: 10.3109/14767058.2015.1024647 pmid: 25777790
[7]	Fohner AE, Garrison NA, Austin MA, et al. Carnitine palmitoyltransferase 1A P479L and infant death: policy implications of emerging data[J]. Genet Med, 2017, 19(8): 851-857. doi: 10.1038/gim.2016.202
[8]	Potter CJ. Cholestasis in the premature infant[J]. Clin Perinatol, 2020, 47(2): 341-354. doi: S0095-5108(20)30021-X pmid: 32439115
[9]	Sanchez SE, Braun LP, Mercer LD, et al. The effect of lipid restriction on the prevention of parenteral nutrition-associated cholestasis in surgical infants[J]. J Pediatr Surg, 2013, 48(3): 573-578. doi: 10.1016/j.jpedsurg.2012.08.016
[10]	Sundekilde UK, Downey E, O'Mahony JA, et al. The effect of gestational and lactational age on the human milk metabolome[J]. Nutrients, 2016, 8(5): 304. doi: 10.3390/nu8050304
[11]	Salguero Olid A, Blanco Sánchez G, Alonso Ojembarrena A. A systematic review about prophylactic L~carnitine administration in parenteral nutrition of extremely preterm infants[J]. Farm Hosp, 2018, 42(4): 168-173.
[12]	Clark MA, Stein REK, Silver EJ, et al. Carnitine deficiency in preterm infants: a national survey of knowledge and practices[J]. J Neonatal Perinatal Med, 2017, 10(4): 381-386. doi: 10.3233/NPM-16146 pmid: 29286927
[13]	Clark RH, Chace DH, Spitzer AR. Impact of L-carnitine supplementation on metabolic profiles in premature infants[J]. J Perinatol, 2017, 37(5): 566-571. doi: 10.1038/jp.2016.253 pmid: 28079870
[14]	Ng K, Stoll B, Chacko S, et al. Vitamin E in new-generation lipid emulsions protects against parenteral nutrition-associated liver disease in parenteral nutrition-fed preterm pigs[J]. JPEN J Parenter Enteral Nutr, 2016, 40(5): 656-671. doi: 10.1177/0148607114567900
[15]	Wang N, Yan W, Hong L, et al. Risk factors of parenteral nutrition-associated cholestasis in very-low-birthweight infants[J]. J Paediatr Child Health, 2020, 56(11): 1785-1790. doi: 10.1111/jpc.14826
[16]	王彩菲. 左卡尼汀在预防早产儿胆汁淤积症的临床对照研究[J]. 中外医学研究, 2019, 17(7): 152-153.

组别	例数	胎龄(x±s)/周	出生体质量(x±s)/g	性别/ 男[n(%)]	Apgar评分[M(P₂₅~P₇₅)]/min		胎膜早破 [n(%)]	产前地塞米松[n(%)]
组别	例数	胎龄(x±s)/周	出生体质量(x±s)/g	性别/ 男[n(%)]	1分钟	5分钟	胎膜早破 [n(%)]	产前地塞米松[n(%)]
左旋肉碱组	139	26.6±1.5	902.9±152.1	82(59.0)	8.0(5.0~10.0)	10.0(9.0~10.0)	39(28.1)	103(74.1)
非左旋肉碱组	122	26.4±1.2	912.3±200.3	69(56.6)	7.0(5.0~9.0)	10.0(9.0~10.0)	40(32.8)	71(58.2)
统计量		t=1.32	t=0.43	χ²=0.16	Z=2.25	Z=0.01	χ²=3.18	χ²=10.22
P		0.189	0.668	0.691	0.025	0.993	0.365	0.017

组别	例数	总胆红素/μmol·L^-1			直接胆红素/μmol·L^-1			胆汁酸/μmol·L^-1
组别	例数	1周	2周	4周	1周	2周	4周	1周	2周	4周
左旋肉碱组	139	99.2 (79.9~140.6)	54.0 (31.5~94.8)	34.4 (18.9~77.9)	6.9 (4.6~8.6)	7.8 (6.0~12.1)	8.1 (6.4~19.7)	18.5 (12.1~24.8)	24.6 (16.6~34.0)	35.9 (23.5~47.8)
非左旋肉碱组	122	120.7 (90.6~145.0)	66.0 (45.5~102.1)	45.0 (26.2~81.0)	6.8 (5.7~8.5)	8.6 (6.7~11.8)	9.9 (7.5~29.5)	18.0 (11.6~23.5)	19.3 (13.6~29.5)	31.7 (22.8~43.3)
Z值		2.07	2.60	1.92	0.97	1.33	2.20	0.48	2.48	1.22
P		0.039	0.009	0.055	0.331	0.183	0.028	0.695	0.013	0.224

组别	例数	胆固醇/mmol·L^-1			三酰甘油/mmol·L^-1
组别	例数	1周	2周	4周	1周	2周	4周
左旋肉碱组	139	3.5(2.9~4.4)	3.2(2.7~3.9)	2.8(2.3~3.6)	1.7(1.1~2.6)	1.3(1.0~2.3)	1.2(0.9~2.0)
非左旋肉碱组	122	3.6(2.5~4.4)	3.3(2.7~3.9)	2.8(2.2~3.3)	1.1(0.7~2.2)	1.3(0.8~2.0)	1.1(0.8~1.7)
Z值		0.23	0.04	0.92	3.48	0.84	0.21
P		0.820	0.971	0.357	0.001	0.400	0.832

组别	例数	ALT/U·L^-1			BUN/mmol·L^-1			CR/μmol·L^-1
组别	例数	1周	2周	4周	1周	2周	4周	1周	2周	4周
左旋肉碱组	139	7.0 (6.0~9.0)	8.0 (7.0~9.8)	9.5 (8.0~13.8)	8.5 (5.9~11.3)	3.3 (2.3~4.7)	1.4 (1.1~2.2)	78.5 (63.8~88.5)	57.0 (48.3~67.8)	44.0 (38.0~51.0)
非左旋肉碱组	122	7.0 (5.0~8.0)	7.0 (6.0~8.0)	9.0 (8.0~12.4)	10.0 (7.4~12.4)	4.5 (2.9~6.3)	1.6 (1.2~2.4)	82.0 (70.3~96.0)	63.0 (53.0~76.0)	46.5 (38.8~55.0)
Z值		2.40	4.93	1.56	2.23	3.65	1.31	2.31	2.34	1.16
P		0.016	<0.001	0.119	0.026	<0.001	0.191	0.021	0.019	0.246

因素	回归系数	标准误	Wald χ²值	OR(95%CI)	P
胎龄	-0.25	0.17	2.07	0.778(0.553~1.095)	0.151
体质量	0.00	0.00	0.34	1.001(0.998~1.003)	0.561
预防性使用左旋肉碱	-0.10	0.38	0.07	0.904(0.433~1.889)	0.789
胆固醇（1周）	-0.16	0.19	0.72	0.852(0.589~1.233)	0.396
胆固醇（2周）	-0.33	0.23	2.06	0.716(0.454~1.130)	0.151
胆固醇（4周）	0.13	0.18	0.49	1.136(0.795~1.625)	0.484
三酰甘油（1周）	0.15	0.11	2.01	1.166(0.943~1.443)	0.157
三酰甘油（2周）三酰甘油（4周）常量	-0.05 0.49 5.17	0.09 0.20 4.23	0.37 6.47 1.50	0.950(0.805~1.122) 1.633(1.119~2.383) 176.23	0.546 0.011 0.222

Effect of L-carnitine on lipid and bilirubin metabolism in extremely premature infants

RichHTML

PDF (PC)

Like

Knowledge

Abstract

Cite this article

share this article

Figures/Tables 5

References 16

Related Articles 3

Metrics

Comments

Recommended 0

[1]	WANG Liping, YOU You, YIN Zhanghua, WANG Yiwen, CHEN Sun, XIA Hongping. Pulmonary vein stenosis in extremely premature infants with bronchopulmonary dysplasia: a report of two cases [J]. Journal of Clinical Pediatrics, 2023, 41(4): 289-293.
[2]	CUI Dong, HU Yuhui, TANG Gen, et al. Clinical and gene mutation characteristics of primary carnitine deficiency and prenatal diagnosis in one case [J]. Journal of Clinical Pediatrics, 2019, 37(6): 449-.
[3]	HUA Yuanyuan, MIAO Jingkun, ZOU Xian, LAI Xin, CHEN Na, YU Linchao, CHEN Qixiong. Clinical characteristics of extremely premature infants at low risk for early-onset sepsis [J]. Journal of Clinical Pediatrics, 2019, 37(1): 1-5.